Prazosin hydrochloride - Generic Drug Details

What are the generic drug sources for prazosin hydrochloride and what is the scope of patent protection?

Prazosin hydrochloride is the generic ingredient in three branded drugs marketed by Pfizer, Alembic, Am Therap, Ani Pharms, Appco, Aurobindo Pharma Ltd, Dava Pharms Inc, Granules, Lannett Co Inc, Mankind Pharma, Mylan, Novitium Pharma, Purepac Pharm, Teva Pharms, and Watson Labs, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for prazosin hydrochloride. Thirty suppliers are listed for this compound.

Summary for prazosin hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	15
NDAs:	24
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	30
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	66
Patent Applications:	2,629
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in prazosin hydrochloride?	prazosin hydrochloride excipients list
DailyMed Link:	prazosin hydrochloride at DailyMed

Recent Clinical Trials for prazosin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ottawa Hospital Research Institute	Early Phase 1
The Royal's Institute of Mental Health Research	Early Phase 1
Aurora Health Care	Phase 3

See all prazosin hydrochloride clinical trials

Pharmacology for prazosin hydrochloride

Drug Class	alpha-Adrenergic Blocker
Mechanism of Action	Adrenergic alpha-Antagonists

Medical Subject Heading (MeSH) Categories for prazosin hydrochloride

Adrenergic alpha-1 Receptor Antagonists

Antihypertensive Agents

US Patents and Regulatory Information for prazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072609-001	May 16, 1989		DISCN	No	No
Dava Pharms Inc	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072705-001	May 16, 1989		DISCN	No	No
Appco	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	213406-001	Oct 21, 2022	AB	RX	No	No
Lannett Co Inc	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	214083-002	Jan 3, 2024	AB	RX	No	No
Mylan	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	072575-001	May 16, 1989	AB	RX	No	No
Novitium Pharma	PRAZOSIN HYDROCHLORIDE	prazosin hydrochloride	CAPSULE;ORAL	210971-001	Oct 3, 2018	AB	RX	No	No

Expired US Patents for prazosin hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-001	Jan 29, 1992
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-003	Approved Prior to Jan 1, 1982
Pfizer	MINIPRESS XL	prazosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	019775-002	Jan 29, 1992
Pfizer	MINIPRESS	prazosin hydrochloride	CAPSULE;ORAL	017442-002	Approved Prior to Jan 1, 1982